Treatment of the patient with deep vein thrombosis.
Weismantel
D
D
Department of Family Practice, Michigan State University, East Lansing, MI 48824, USA. david.weismantel@ht.msu.edu
D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001458:Bandages / Q000191:economics / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D012307:Risk Factors; D020246:Venous Thrombosis / Q000191:economics / Q000628:therapy*; D014859:Warfarin / Q000008:administration & dosage / Q000627:therapeutic use
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D014859:Warfarin; D006493:Heparin